Novo método quantitativo para avaliação da gama de hospedeiros de bacteriófagos desenvolvido em colaboração entre a Proteon Pharmaceuticals e o Instituto de Biologia Médica PAS
Scientists from Proteon Pharmaceuticals S.A., in collaboration with researchers from the Institute of Medical Biology Polish Academy of Sciences, have developed a new quantitative method for
Proteon Pharmaceuticals publica nova pesquisa sobre a arquitetura da ponta da cauda do bacteriófago
Our researchers have recently published their latest article in Frontiers in Microbiology, a paper titled “Revisiting Phage Tail Spike Architecture: Evidence for Undetected Receptor-Binding Proteins
The EU Approves BAFASAL® – First Bacteriophage-Based Zootechnical Feed Additive for Poultry
Proteon Pharmaceuticals is pleased to confirm that BAFASAL®, its pioneering bacteriophage-based feed additive, has received full regulatory approval from the European Union for use in
BAFASAL® Moves Closer to EU Authorisation
Following the Standing Committee on Plants, Animals, Food and Feed (PAFF Committee) recent meeting in Brussels, Proteon Pharmaceuticals is pleased to share a significant development
Oportunidades e desafios da terapia com fagos na aquicultura moderna
A 2020 study published in Viruses (MDPI), titled “Growing Trend of Fighting Infections in Aquaculture Environment – Opportunities and Challenges of Phage Therapy”, provides a
Solução Inovadora no Diagnóstico de APEC: Resultados da Pesquisa Mais Recente
A team of scientists from Proteon Pharmaceuticals, the Biobank Lodz, and the University of Agriculture in Cracow has developed an innovative method for identifying strains